{
    "nctId": "NCT05371847",
    "briefTitle": "Identifying Prognostic Variables for Persistent UL Dysfunctions After Breast Cancer Treatment -Reliability and Validity",
    "officialTitle": "Identifying Prognostic Variables for Persistent Upper Limb Dysfunctions After Breast Cancer Treatment: Longitudinal Cohort Study",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NON_RANDOMIZED",
    "primaryPurpose": "SCREENING",
    "enrollmentCount": 150,
    "primaryOutcomeMeasure": "Reliability of measurements with MyotonPro",
    "eligibilityCriteria": "Inclusion Criteria for breast cancer patients\n\n* Patients scheduled for surgery (mastectomy or breast conserving surgery; in combination with axillary lymph node dissection or sentinel node biopsy) for unilateral primary breast cancer or patients with oligometastatic breast cancer.\n* Patients who receive adjuvant radiotherapy .\n* Patients with a cognitive and language functioning enabling coherent Dutch communication between the examiner and the participant\n* Patients who can comply with the protocol at baseline assessment and willing to provide written informed consent\n\nInclusion criteria healthy volunteers\n\n* Healthy women and men(quickDASH\\<15) age- and gender-matched with a breast cancer patient from the main study\n* Volunteers who can comply with the protocol at baseline assessment and willing to provide written informed consent\n\nExclusion Criteria breast cancer patients\n\n* BCS with widespread distance metastases, previous breast surgery, or planned bilateral surgery\n* And/or with a diagnosis of a neurological or rheumatological condition, diabetes,\n* And/or BCS who are not available the entire duration of the study\n\nExclusion Criteria healthy volunteers\n\n* History of breast cancer\n* Patients with a diagnosis of neurological or rheumatological condition, diabetes",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}